Showing 9301-9310 of 20377 results for "".
- Unlocking Equitable Care: Navigating Healthcare Access and Innovative Practices in Obesity Managementhttps://reachmd.com/news/unlocking-equitable-care-navigating-healthcare-access-and-innovative-practices-in-obesity-management/2483579/The challenges of healthcare access perpetuate both stigma and delayed treatment, impacting metabolic health. Delays in imaging and specialty referrals can mean missed NAFLD screening, postponed diabetes management, and fewer opportunities for early intervention. Pat
- Revolutionizing Wound Care: Integrating Biochemical Monitoring and Bioengineered Materialshttps://reachmd.com/news/revolutionizing-wound-care-integrating-biochemical-monitoring-and-bioengineered-materials/2474913/In today’s wound care clinic, a patient with a non-healing diabetic ulcer demonstrates the limitations of traditional visual assessments, demanding new strategies to detect unseen biochemical disruptions and guide intervention. The wou
- Macrophage Dysfunction in TB-DM: Exploring Immune Dysregulation and Inflammationhttps://reachmd.com/news/macrophage-dysfunction-in-tb-dm-exploring-immune-dysregulation-and-inflammation/2474424/This article examines the significant impact of macrophage dysfunction in the context of comorbid tuberculosis and diabetes mellitus, highlighting how impaired phagocytosis and cytokine imbalances contribute to chronic inflammation and persistent bacterial presence in affec
- Exploring the Impact of Depression on Perceived Health: Insights from Korean Womenhttps://reachmd.com/news/exploring-the-impact-of-depression-on-perceived-health-insights-from-korean-women/2471421/Recent findings from a cross-sectional study of Korean adult women reveal that depression significantly undermines self-perceived health, surpassing the impact of chronic diseases such as hypertension, diabetes, and dyslipidemia. This article explores the implications of th
- Fruit Fly Insights Illuminate Insulin Production Mechanismshttps://reachmd.com/news/fruit-fly-insights-illuminate-insulin-production-mechanisms/2471363/What's New This article explores how insulin-producing cells in fruit flies react to metabolic changes, offering valuable insights into diabetes management. Significance The research bridges a gap in understanding insulin regulation mechanisms, poten
- Harnessing Retinal Imaging for Early Disease Detectionhttps://reachmd.com/news/harnessing-retinal-imaging-for-early-disease-detection/2471335/Innovative research reveals the potential of high-resolution retinal maps for early disease diagnosis, providing new perspectives on conditions such as diabetes and dementia. Importance The article delves into how AI-driven high-resolution retinal imaging can
- Insights from a New Rabbit Model in Cystic Fibrosis Researchhttps://reachmd.com/news/insights-from-a-new-rabbit-model-in-cystic-fibrosis-research/2470992/What's New A novel rabbit model offers promising insights into the pancreatic complications associated with cystic fibrosis, potentially reshaping diabetes management in CF patients. Significance This research is crucial as it opens avenues for bette
- Understanding Semaglutide's Impact on Optic Health: A Closer Look at Emerging Riskshttps://reachmd.com/news/understanding-semaglutides-impact-optic-health-closer-look-emerging-risks/2470788/What's New Recent studies suggest a potential link between semaglutide, a popular medication for diabetes and weight management, and the risk of developing nonarteritic anterior ischemic optic neuropathy (NAION). This raises important questions for healthcare professionals
- CHOICE-2 Trial: Intra-Arterial Alteplase After Thrombectomyhttps://reachmd.com/news/choice-2-intra-arterial-alteplase-thrombectomy/2487548/Key Takeaways Adjunctive intra-arterial alteplase after thrombectomy was associated with more patients reaching mRS 0 or 1 at 90 days. Lower residual hypoperfusion on follow-up CT perfusion was reported with adjunctive alteplase. Symptomatic i
- Pimavanserin Trial Finds No Efficacy Signal in Irritability in Pediatric ASDhttps://reachmd.com/news/pimavanserin-pediatric-asd-irritability/2487251/Key Takeaways In pediatric ASD, neither low-dose nor high-dose pimavanserin differed significantly from placebo on week-6 caregiver-rated ABC-I change. No secondary endpoint showed a statistically significant difference between pimavanserin and placebo